Showing results (151-160 of 172) with videos related to

Sort By:
Pageof 18
JAMA Neurology|October 31, 2012
Acute silent cerebral ischemic events in children with sickle cell anemiaCharles T Quinn, Robert C McKinstry, Michael M Dowling, et al.
Pediatric Hematology and Oncology|March 6, 2010
Design of the silent cerebral infarct transfusion (SIT) trialJames F Casella, Allison A King, Bruce Barton, et al.
JAMA|November 22, 2001
Purified poloxamer 188 for treatment of acute vaso-occlusive crisis of sickle cell disease: A randomized controlled trialE P Orringer, J F Casella, K I Ataga, et al.
The Journal of Pediatrics|November 11, 2006
Exchange blood transfusion compared with simple transfusion for first overt stroke is associated with a lower risk of subsequent stroke: a retrospective cohort study of 137 children with sickle cell anemiaMonica L Hulbert, Douglas J Scothorn, Julie A Panepinto, et al.
Pediatric Blood & Cancer|September 5, 2009
The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study designBruce W Thompson, Scott T Miller, Zora R Rogers, et al.
Blood|October 14, 2010
Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell diseaseMonica L Hulbert, Robert C McKinstry, JoAnne L Lacey, et al.
British Journal of Haematology|September 11, 2012
Magnetic resonance angiography-defined intracranial vasculopathy is associated with silent cerebral infarcts and glucose-6-phosphate dehydrogenase mutation in children with sickle cell anaemiaMathula Thangarajh, Genyan Yang, Dana Fuchs, et al.
Blood|September 2, 2009
Serum ferritin level changes in children with sickle cell disease on chronic blood transfusion are nonlinear and are associated with iron load and liver injuryThomas V Adamkiewicz, Miguel R Abboud, Carole Paley, et al.
Plos One|May 5, 2012
A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemiaJacqueline N Milton, Paola Sebastiani, Nadia Solovieff, et al.
The Journal of Pediatrics|April 16, 2002
Risk of recurrent stroke in children with sickle cell disease receiving blood transfusion therapy for at least five years after initial strokeDouglas J Scothorn, Cynthia Price, Daniel Schwartz, et al.
Pageof 18